|
globalpharma
Co.
LLC
- a
joint venture,is Dubai's first pharmaceutical
manufacturing company which is
designed
to global standards.
It is a subsidiary of Dubai Investment
PJSC - one of the leading
organization in the United Arab Emirates with a subscribed
capital of
approx. US $ 350 million,
which was founded in 1995
with the aim of
promoting business
opportunities in the United Arab Emirates.
While
Dubai Investments holds 65% equity in globalpharma,
the rest 35%
equity is with Kopran
Ltd.,one of the leading
healthcare concerns in
India, promoted by Parijat Enterprises.
Kopran is also providing
technology transfer to globalpharma
for the manufacturing facility
built at a cost of
approximately US$ 20 million.
globalpharma
is committed
to offering international
quality
pharmaceutical products to the Middle
East as well as global
markets.
We aim to create
a regional model for manufacturing
excellence in a
sector where quality is
paramount.
Besides
marketing and distributing our products,
globalpharma is
actively exploring the following:
1. Contract Manufacturing for internationally well known
pharmaceutical companies.
2. Exporting products to leading organizations
globally.
3.
"Licensing-in" products of multinational
pharmaceutical companies
which will supplement/complement our existing range.
4. Marketing and distributing products of multinational
pharmaceutical
companies in the Arab world.
|
